| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.078 | 0.2 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.2 |